These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8583237)

  • 1. Administration of myelin basic protein synthetic peptides to multiple sclerosis patients.
    Warren KG; Catz I
    J Neurol Sci; 1995 Nov; 133(1-2):85-94. PubMed ID: 8583237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intrathecal MBP synthetic peptides containing epitope P85 VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis.
    Warren KG; Catz I
    J Neurol Sci; 1997 May; 148(1):67-78. PubMed ID: 9125392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients.
    Warren KG; Catz I
    Mult Scler; 2000 Oct; 6(5):300-11. PubMed ID: 11064438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
    Warren KG; Catz I
    J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
    Warren KG; Catz I
    J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis anti-myelin basic protein synthetic peptide specificity.
    Warren KG; Catz I; Shutt K
    J Neurol Sci; 1992 May; 109(1):88-95. PubMed ID: 1381412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
    Catz I; Warren KG
    Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases.
    Warren KG; Catz I
    J Neurol Sci; 1989 Jun; 91(1-2):143-51. PubMed ID: 2473170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
    Warren KG; Catz I
    J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis.
    Warren KG; Catz I; Wucherpfennig KW
    J Neurol Sci; 1997 Nov; 152(1):31-8. PubMed ID: 9395124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
    Warren KG; Catz I
    J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
    Warren KG; Catz I
    J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.
    Warren KG; Catz I; Ferenczi LZ; Krantz MJ
    Eur J Neurol; 2006 Aug; 13(8):887-95. PubMed ID: 16879301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neuroimmunol; 1992 Jul; 39(1-2):81-9. PubMed ID: 1377712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
    O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
    J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
    Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
    J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis.
    Martino G; Olsson T; Fredrikson S; Hojeberg B; Kostulas V; Grimaldi LM; Link H
    Eur J Immunol; 1991 Dec; 21(12):2971-6. PubMed ID: 1721023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.
    Warren KG; Catz I; Jeffrey VM; Carroll DJ
    Can J Neurol Sci; 1986 Feb; 13(1):25-30. PubMed ID: 2420429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.